Answers are grounded in this paper and cite their sources.
The catalytic enantioselective synthesis of the chiral key intermediate of the antidepressant (-)-paroxetine is demonstrated as a continuous flow process on multi-gram scale. The critical step is a solvent-free organocatalytic conjugate addition followed by a telescoped reductive amination-lactamization-amide/ester reduction sequence. Due to the efficient heterogeneous catalysts and the solvent-free or highly concentrated conditions applied, the flow method offers key advances in terms of productivity and sustainability compared to earlier batch approaches.
No takes yet. Share an insight, caveat, or question.
Ötvös et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: